Nicolas Fischer
Directeur Général chez Berta Holding AG
Profil
Nicolas Fischer is currently the Chief Executive Officer & Director at Coty Brasil Comércio SA and the Managing Director at Berta Holding AG.
He obtained an undergraduate degree from Technische Universität Bergakademie Freiberg.
Postes actifs de Nicolas Fischer
| Sociétés | Poste | Début |
|---|---|---|
Berta Holding AG
 Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Directeur Général | - |
Coty Brasil Comércio SA
 Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Directeur Général | - |
Formation de Nicolas Fischer
| Technische Universität Bergakademie Freiberg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Coty Brasil Comércio SA
Coty Brasil Comércio SA Medical DistributorsDistribution Services Coty Brasil Comércio SA engages in the retail of cosmetic products. It operates as a group managing several cosmetic brands. The company was founded in 1995 and is headquartered in Goiania, Brazil. | Distribution Services |
Berta Holding AG
Berta Holding AG BiotechnologyHealth Technology Berta Holding AG engages in the research, development, production, licensing and marketing of pharmaceuticals. Its products include medicines and medical therapies, particularly antibody-based therapies for cancer, immune system disorders, and infectious diseases. The company was founded on September 03, 2018 and is headquartered in Pfäffikon, Switzerland. | Health Technology |
